DPP4 and type 2 diabetes mellitus: Beyond their primary role in improving glycemic control in patients with T2DM, DPP-4 inhibitors also demonstrate different effects on bone metabolism [107], e.g., through actions on DPP-4 substrates and adipokines [99].